weight loss ~21% over 72 wks Dual GIP / GLP-1 Included *Average weight-loss figures reference published clinical trials (STEP for semaglutide, SURMOUNT for tirzepatide)
Choosing the Right Injection Site and Technique The abdomen (at least 5 cm from the navel), outer thigh, and outer upper arm are the recommended subcutaneous injection sites
an area of active research interest General gut health and microbiome support: systemic GI protocol for patients with chronic digestive dysfunction Post-antibiotic gut recovery: mucosal restoration support for patients recovering from significant antibiotic courses that have disrupted gut mucosal integrity Oral BPC-157 is distinguished from injectable BPC-157 by its site of action: oral administration delivers the peptide directly to the gastric and intestinal mucosa, where it acts locally on the tissue it is most needed in
(Link) Nurses Top Healthcare Ratings: A Gallup poll shows nurses earning the highest grades for care, far above other healthcare workers
British Journal of Anaesthesia
doi: 10.1111/1751-7915.12778 Summary Keywords MOTS-c, mitochondrial-derived peptide, therapeutic exploitation, synthetic biology, endocrine Citation Zheng Y, Wei Z and Wang T (2023) MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
